M.D. Sass Concentrated Equities ETF
SASS
New York Stock Exchange Arca24.90
USD
-0.21
- -
ISIN
US75526L6130
CUSIP
75526L613
Return %
Stock
S&P500
1Y
-0.40
26.53
3Y
-0.40
76.60
5Y
-0.40
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Ari D. Sass
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 80 Pine Street, 21st Floor New York NY United States of America 10005
- IPO Date
- Mar 4, 2026
- Website
- mdsass.com
- Similar Companies
- Business
- M.D. Sass Concentrated Equities ETF (SASS) is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing in a concentrated portfolio of 15 to 25 high-conviction equity securities selected through a value-oriented investment approach. The fund's core offerings include concentrated equity positions in undervalued companies across various sectors such as technology, healthcare, consumer discretionary, and financials; it employs a fundamental research process emphasizing strong balance sheets, attractive valuations, and catalysts for growth, with holdings typically featuring low price-to-earnings ratios and high free cash flow yields. SASS targets sophisticated investors seeking differentiated returns from benchmark indices like the S&P 500, with a focus on tax-efficient strategies including direct indexing capabilities for customization. Founded in 2024 and headquartered in New York, New York, as a product of M.D. Sass Investors, L.L.C., the ETF operates primarily in the U.S. equity markets through its sponsor and investment adviser, Tidal ETF Services LLC, in partnership with M.D. Sass as sub-adviser. Geographically, it invests globally but with a primary emphasis on U.S.-listed securities. In recent developments, the fund launched on the NYSE Arca exchange in late 2024, marking M.D. Sass's entry into the ETF space as its inaugural product; it has since grown assets under management through strategic marketing to high-net-worth individuals and family offices, alongside a 2025 partnership expansion with Tidal Investments LLC to enhance distribution channels. No major acquisitions or reorganizations have been reported, though the firm continues to emphasize concentrated equity strategies amid market volatility in 2025-2026.
Amid AI Stock Dominance, MD Sass Rolls Out High-Conviction Value ETF